(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy
Medicinal Research Reviews · 2023-11 · 43 (6) · 2115-2176
DOI: 10.1002/med.21971 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 11.05.2023. Verfasst von Milad Ashrafizadeh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Carson International Cancer Center, Shen…. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 206-mal zitiert (Crossref) und nennt 343 Literaturangaben.
Abstract (Originalsprache)
Breast cancer is the most malignant tumor in women, and there is no absolute cure for it. Although treatment modalities including surgery, chemotherapy, and radiotherapy are utilized for breast cancer, it is still a life‐threatening disease for humans. Nanomedicine has provided a new opportunity in breast cancer treatment, which is the focus of the current study. The nanocarriers deliver chemotherapeutic agents and natural products, both of which increase cytotoxicity against breast tumor cells and prevent the development of drug resistance. The efficacy of gene therapy is boosted by nanoparticles and the delivery of CRISPR/Cas9, Noncoding RNAs, and RNAi, promoting their potential for gene expression regulation. The drug and gene codelivery by nanoparticles can exert a synergistic impact on breast tumors and enhance cellular uptake via endocytosis. Nanostructures are able to induce photothermal and photodynamic therapy for breast tumor ablation via cell death induction. The nanoparticles can provide tumor microenvironment remodeling and repolarization of macrophages for antitumor immunity. The stimuli‐responsive nanocarriers, including pH‐, redox‐, and light‐sensitive, can mediate targeted suppression of breast tumors. Besides, nanoparticles can provide a diagnosis of breast cancer and detect biomarkers. Various kinds of nanoparticles have been employed for breast cancer therapy, including carbon‐, lipid‐, polymeric‐ and metal‐based nanostructures, which are different in terms of biocompatibility and delivery efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guang…
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, Turkey.
- Institute of Polymers, Composites and Biomaterials - National Research Council (IPCB-CNR), Naples, Italy.
- Department of Orthopedics, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
ORCID-Profile: Gautam Sethi
Zitieren
APA
Ashrafizadeh, M., Zarrabi, A., Bigham, A., Taheriazam, A., Saghari, Y., Mirzaei, S., Hashemi, M., Hushmandi, K., Karimi-Maleh, H., Nazarzadeh Zare, E., Sharifi, E., Ertas, Y. N., Rabiee, N., Sethi, G., & Shen, M. (2023). (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy. Medicinal Research Reviews, 43(6), 2115-2176. https://doi.org/10.1002/med.21971
Vancouver
Ashrafizadeh M, Zarrabi A, Bigham A, Taheriazam A, Saghari Y, Mirzaei S, et al. (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy. Medicinal Research Reviews. 2023;43(6):2115-2176. doi:10.1002/med.21971
BibTeX
@article{Ashrafizadeh2023,
author = {Ashrafizadeh, Milad and Zarrabi, Ali and Bigham, Ashkan and Taheriazam, Afshin and Saghari, Yalda and Mirzaei, Sepideh and Hashemi, Mehrdad and Hushmandi, Kiavash and Karimi-Maleh, Hassan and Nazarzadeh Zare, Ehsan and Sharifi, Esmaeel and Ertas, Yavuz Nuri and Rabiee, Navid and Sethi, Gautam and Shen, Mingzhi},
title = {(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy},
journal = {Medicinal Research Reviews},
year = {2023},
volume = {43},
number = {6},
pages = {2115--2176},
doi = {10.1002/med.21971}
}
EUVIMED